For research use only. Not for human consumption.
The Wolverine Stack is a biological peptide research combination uniting BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 synthetic analog).
$75.00
The Wolverine Stack is a biological peptide research combination uniting BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4 synthetic analog). Colloquially named after its rapid tissue recovery properties, this dual-peptide blend combines localized cellular repair signaling with systemic cell migration and vascular formation mechanisms.
Angiogenesis & Tissue Repair: Studied for BPC-157’s up-regulation of VEGFR2 expression to accelerate new blood vessel growth directly at damaged tissue sites.
Actin Regulation & Cell Migration: Evaluated for TB-500’s G-actin sequestering capabilities, promoting cellular migration, fibroblast movement, and structural matrix reorganization.
Tendon, Ligament & Joint Recovery: Researched in musculoskeletal injury models for synergistic acceleration of collagen synthesis, connective tissue repair, and inflammation reduction.
To provide a combined regenerative peptide complex for investigating accelerated musculoskeletal recovery, microvascular formation, cellular migration, and extracellular matrix healing in laboratory research.
| Property | Details |
| Product Name | Wolverine Stack (BPC-157 5mg + TB-500 5mg) |
| Product Category | Regenerative & Tissue Repair Peptides |
| Compound Type | Gastric Pentadecapeptide / Thymosin Beta-4 Fragment Dual Blend |
| Primary Goal | Angiogenesis acceleration, tendon and ligament repair, and actin-mediated cell migration research |
| Form | Lyophilized powder (vial) |
| Storage | Store lyophilized powder at 2°C to 8°C (refrigerated) or -20°C for long-term storage. |
| Protect from direct light. | |
| Dosage | 5MG |
|---|
Explore similar research-grade peptides, selected to complement your research needs.
By proceeding you affirm the statements above are true. This site uses cookies to remember your verification status. Privacy Policy.
